Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,997 | 54,627 | 64,474 | 80,506 | 119,356 |
| Marketable Securities | 499,586 | 233,281 | 244,667 | 215,214 | 161,792 |
| Receivables | N/A | N/A | N/A | 6,204 | 3,846 |
| Other current assets | 0 | 0 | 0 | 0 | 7,500 |
| TOTAL | $619,387 | $295,503 | $318,449 | $311,118 | $298,434 |
| Non-Current Assets | |||||
| PPE Net | 17,757 | 16,808 | 17,163 | 11,340 | 6,672 |
| Investments And Advances | 0 | 7,421 | 63,879 | 137,189 | 90,890 |
| Other Non-Current Assets | 32,199 | 35,866 | 17,268 | 17,124 | 347 |
| TOTAL | $49,956 | $60,095 | $98,310 | $165,653 | $97,909 |
| Total Assets | $669,343 | $355,598 | $416,759 | $476,771 | $396,343 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,482 | 6,401 | 5,064 | 6,650 | 3,412 |
| Accrued Expenses | 37,994 | 24,970 | 22,428 | 14,549 | 8,328 |
| TOTAL | $95,854 | $86,958 | $70,655 | $66,258 | $44,539 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 38,364 | 48,098 | 37,633 | 41,212 | 32,799 |
| Other Non-Current Liabilities | 20,289 | 23,125 | 6,434 | 9,189 | 850 |
| TOTAL | $46,496 | $68,147 | $42,408 | $68,211 | $61,535 |
| Total Liabilities | $142,350 | $155,105 | $113,063 | $134,469 | $106,074 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,887 | 48,894 | 47,273 | 44,738 | 38,907 |
| Common Shares | 76 | 49 | 47 | 45 | 39 |
| Retained earnings | -738,769 | -545,200 | -401,252 | -220,892 | -103,698 |
| Other shareholders' equity | 150 | -655 | -4,319 | -608 | 87 |
| TOTAL | $526,993 | $200,493 | $303,696 | $342,302 | $290,269 |
| Total Liabilities And Equity | $669,343 | $355,598 | $416,759 | $476,771 | $396,343 |